NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
RIGL Rigel Pharmaceuticals
- 22.330
- +0.830+3.86%
Close Feb 26 16:00 ET
- 21.920
- -0.410-1.84%
Pre 04:45 ET
393.34MMarket Cap82.70P/E (TTM)
22.800High21.500Low265.52KVolume21.500Open21.500Pre Close5.92MTurnover1.76%Turnover RatioLossP/E (Static)17.62MShares29.82052wk High-26.87P/B337.01MFloat Cap7.48452wk Low--Dividend TTM15.09MShs Float1147.499Historical High--Div YieldTTM6.05%Amplitude6.400Historical Low22.304Avg Price1Lot Size
Rigel Pharmaceuticals Stock Forum
21.+
and back to 20.+
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
WSJ· 08:36
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
Thursday, 9th January at 8:05 am
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to R289 for the treatment of myelodysplastic syndromes (MDS). R2891, ...
No comment yet